logo
Veterinarians make disturbing discovery after analyzing elephant's cause of death: 'This is so sad'

Veterinarians make disturbing discovery after analyzing elephant's cause of death: 'This is so sad'

Yahoo6 days ago

An elephant died in Tamil Nadu, India, after scavenging at a trash heap.
Veterinarians who tried to save the animal found plastic bags and aluminum foil in its intestines during a necropsy, the Hindu reported. The trash included single-use bags and polythene snack packaging.
The elephant, which was 12-15 months pregnant and accompanied by a calf, was seen near Bharathiar University in Coimbatore. After it collapsed, a Forest Department team tried to save it, providing hydrotherapy, fluids, and other treatment for three days.
Officials attributed the creature's death to multi-organ failure caused by septicemia. They noted its heart and liver were unhealthy.
"This is so sad," one X user said.
"Heartbreaking," someone else wrote. "Ban single-use plastic bags. Bring in strict fines for those who break the rules. We also need to run strong public campaigns on how plastic harms animals, marine life, spoils beaches, and affects our health."
The improper disposal of plastic and other waste causes the deaths of countless beings every year. It also pollutes the environment and affects humans in a number of ways, as people rely on nature's biodiversity for food as well as stable climate systems.
The Asian elephant is one of the largest land mammals in the world. They are highly intelligent, socially adept, and endangered. The three subspecies may number less than 50,000 individuals, as human development for communities, infrastructure, and agriculture limit wildlife habitat around the world.
This increases encounters between wild animals and humans, leading to dangerous situations for all involved.
The dump where the elephant is thought to have consumed garbage is near a forest, per the Hindu. It was cleared and fenced off, as the news outlet's reporting led to a remediation effort.
Do you think America has a plastic waste problem?
Definitely
Only in some areas
Not really
I'm not sure
Click your choice to see results and speak your mind.
You can take similar steps to protect wildlife and clean up your community. Use less plastic by ditching single-use bags, water bottles, food containers, and more for reusable alternatives.
Contact local authorities about illegal dumping, and organize litter pickups by spreading word among family and friends.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why has there been a global surge of new Covid variant NB.1.8.1?
Why has there been a global surge of new Covid variant NB.1.8.1?

Yahoo

timean hour ago

  • Yahoo

Why has there been a global surge of new Covid variant NB.1.8.1?

India is the latest country to report a surge in new Covid cases, as the latest variant NB.1.8.1 spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UKHSA recorded the first 13 cases in England last week. However, the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent one month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at Pall Mall Medical, added: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Dr Asif. Common symptoms of the NB.1.8.1 variant include a severe sore throat. fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.

Miller Children's & Women's Hospital Long Beach Transforms Maternal Care, Champions Equity and Dignity for All Mothers
Miller Children's & Women's Hospital Long Beach Transforms Maternal Care, Champions Equity and Dignity for All Mothers

Los Angeles Times

timean hour ago

  • Los Angeles Times

Miller Children's & Women's Hospital Long Beach Transforms Maternal Care, Champions Equity and Dignity for All Mothers

Although in some areas, Diversity, Equity, and Inclusion (DEI) initiatives may be declining in healthcare, birth equity remains a priority for many hospitals in California, including Miller Children's & Women's Hospital in Long Beach. Raising awareness and developing strategies for birth equity is crucial to addressing racial and social disparities in maternal and infant health outcomes. In the United States, Black and Hispanic mothers are significantly more likely to experience complications during childbirth and have higher mortality rates as compared to other groups. At Miller Children's & Women's Hospital in Long Beach, over 5,500 babies are born each year. Our community is diverse, with many of our mothers coming from Black, Hispanic, Pacific Islander and other non-white backgrounds. According to the United States Census Bureau, approximately 43.4% of Long Beach's population identifies as Hispanic or Latino, 11.9% as Black or African American and 12.8% as Asian. The city also has a significant Cambodian community, which is the second-largest outside of Cambodia. As a community hospital serving the greater Long Beach area, we prioritize training and awareness around unconscious bias among our patients and caregivers. We have the necessary tools to effectively record and analyze data. Statistics from the Center for Disease Control and Prevention indicate that the maternal mortality rate for non-Hispanic Black women is 49.5 deaths per 100,000 live births – significantly higher than for White (19), Hispanic (16.9) and Asian (13.2) women in 2022. These disparities highlight the urgent need for focused interventions and systemic changes in maternal healthcare. Several factors contribute to the higher maternal mortality in minority communities. Structural racism and implicit bias within the healthcare system can lead to inadequate prenatal care, delayed diagnosis and treatment of pregnancy-related complications, and disparities in access to maternal healthcare services. Furthermore, socioeconomic factors further exacerbate these disparities in maternal outcomes among minority women. Addressing the crisis requires removing systemic barriers to quality maternal healthcare. Miller Children's & Women's Hospital recognizes the ongoing work needed in minority health and has made it a priority. No one should be denied basic or standard healthcare due to their race or ethnicity. Therefore, we are committed to becoming the change, recognizing that much work lies ahead. At the Cherese Mari Laulhere BirthCare Center at Miller Children's & Women's, our healthcare providers and care teams undergo cultural competency training to better understand the unique needs and experiences of minority patients. Additionally, we have partnered with the California Maternal Quality Care Collaborative as one of five hospitals selected for their significant demographics of racial and ethnic minority populations. This partnership focuses on addressing birth inequities, educating staff, sharing data and creating a Hospital Action Guide to empower hospitals nationwide to engage in this vital work. Since focusing on these initiatives, we have seen an almost 10% increase in Black mothers reporting that they always feel like they are treated with courtesy and respect. These patient-reported measures enhance the relationship between the patients and care providers to ensure that patients' voices are heard and that their birth experience preferences are honored. Evidence indicates that these improvements will help close the disparity gap in birth outcomes for Black women and their newborns. Currently, Miller Children's & Women's is working to implement all recommendations from the Association of Women's Health, Obstetric and Neonatal Nurses' (AWHONN) respectful maternal care framework and evidence-based clinical practice guidelines. Our care teams, including our Respectful Maternal Care Champions, are here to enhance the overall experience of our Black and Brown patients, utilizing technology like Irth App, a unique Yelp-like platform for parents of color to leave and find reviews of OB/GYNs, birthing hospitals and pediatricians. By analyzing patient responses shared through this app, we can redefine our care based on patient experiences and make births safer, more respectful and equitable. Want to learn more? Visit

Asian Market Insights: Viva Goods And Two Other Prominent Penny Stocks
Asian Market Insights: Viva Goods And Two Other Prominent Penny Stocks

Yahoo

time12 hours ago

  • Yahoo

Asian Market Insights: Viva Goods And Two Other Prominent Penny Stocks

As global markets navigate a complex landscape, Asian economies remain a focal point for investors seeking diverse opportunities. Penny stocks, often associated with smaller or emerging companies, continue to offer intriguing potential despite their vintage label. By focusing on those with robust financials and clear growth trajectories, these stocks can present hidden gems within the broader market landscape. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.099 SGD42.08M ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$719.28M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.89 HK$3.27B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.06 HK$1.72B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.17 HK$1.95B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.29 SGD9.01B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.179 SGD35.66M ★★★★★★ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.39 HK$50.29B ★★★★★★ Click here to see the full list of 1,153 stocks from our Asian Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Viva Goods Company Limited is an investment holding company that supplies apparel and footwear across various regions including the United Kingdom, the Republic of Ireland, the United States, China, Asia, Europe, the Middle East, and Africa with a market cap of HK$3.39 billion. Operations: The company generates revenue through two main segments: Sports Experience, contributing HK$559.30 million, and Multi-Brand Apparel and Footwear, which accounts for HK$9.87 billion. Market Cap: HK$3.39B Viva Goods Company Limited, with a market cap of HK$3.39 billion, operates in the apparel and footwear sectors across various regions. The company reported revenues of HK$10.43 billion for 2024 but remains unprofitable with a net loss of HK$70.41 million, though this is an improvement from the previous year. Recent share repurchase announcements could enhance shareholder value by increasing net asset value per share and earnings per share. Despite its losses, Viva Goods has a strong cash position exceeding its debt and covers both short-term and long-term liabilities effectively with assets totaling HK$5 billion against liabilities of HK$3.5 billion short-term and HK$2 billion long-term. Click here and access our complete financial health analysis report to understand the dynamics of Viva Goods. Gain insights into Viva Goods' past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥2.49 billion. Operations: Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported any specific revenue segments. Market Cap: CN¥2.49B Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥2.49 billion, shows signs of financial improvement despite its unprofitable status over recent years. The company reported a net income of CN¥8.92 million for Q1 2025, contrasting with a loss the previous year, and annual revenue growth from CN¥213.88 million to CN¥270.26 million in 2024. Its strong cash position covers both short-term liabilities (CN¥70.9M) and long-term liabilities (CN¥2.9M), while remaining debt-free enhances financial stability amidst volatility in earnings and negative return on equity (-15.54%). Management's experience further supports potential operational resilience. Jump into the full analysis health report here for a deeper understanding of Qinghai Spring Medicinal Resources Technology. Review our historical performance report to gain insights into Qinghai Spring Medicinal Resources Technology's track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Lecron Industrial Development Group Co., Ltd. operates in the industrial development sector and has a market cap of CN¥4.54 billion. Operations: Lecron Industrial Development Group Co., Ltd. has not reported any specific revenue segments. Market Cap: CN¥4.54B Lecron Industrial Development Group's recent financial performance indicates a shift to profitability, with Q1 2025 net income at CN¥5.02 million compared to a loss the previous year. Despite this positive turn, the company faces challenges like low return on equity (2.1%) and negative operating cash flow, which impacts debt coverage. However, its short-term assets of CN¥1.3 billion significantly exceed liabilities, providing some financial cushion. The company has also initiated a share buyback program worth up to CN¥100 million to support equity incentives, while its experienced management team offers potential stability amidst high stock volatility. Dive into the specifics of Lecron Industrial Development Group here with our thorough balance sheet health report. Assess Lecron Industrial Development Group's previous results with our detailed historical performance reports. Click through to start exploring the rest of the 1,150 Asian Penny Stocks now. Ready To Venture Into Other Investment Styles? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:933 SHSE:600381 and SZSE:300343. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store